Table 1.

Demographic Characteristics of Patients

	All Patients	Clinical Responders at First Week (n = 33)	Clinically Non-responders at First Week (n = 7)	P (Responders vs. Non-responders)
Age (years)	34.7 ± 12.8	34.9 ± 12.6	33.4 ± 14.3	.78
Gender (W/M) (N/%)	13/27 (32.5/67.5)	11/22 (27.5/55)	2/5 (5/12.5)	.8
Disease duration (months)	49.3 ± 50.6	52.2 ± 54.5	35.5 ± 22.2	.2
Involvement of ulcerative colitis (diffuse/left colon) (n, %)	35/5 (87.5/12.5)	29 (72.5)/4(10)	6 (15)/1(2.5)	.83
Mayo endoscopic score 2 (N/%)	18/40 (45)	18 (54.5)	0	.011
Mayo endoscopic score 3 (N/%)	22/40 (55)	15 (45.5)	7 (100)
Basal Lichtiger score	13.1 ± 2	12.9 ± 2.2	13.6 ± 1.3	.48
AZA usage (experienced /naive) (N/%)	20/20 (50/50)	16/17 (40/42.5)	4/3 (10/ 7.5)	.68
Leukocyte	12 600 ± 11 800	13 000 ± 12 400	9100 ± 4800	.6
Hemoglobulin	10.9 ± 2	11 ± 1.8	9.4 ± 3.5	.19
CRP	43.7 ± 45.3	44 ± 48	39 ± 2	.89
Statistical significance was accepted as p<0.05.